William L. Dewey

William L. Dewey's AcademicInfluence.com Rankings

William L. Dewey

Medical

#2309

World Rank

#2725

Historical Rank

Pharmacology

#239

World Rank

#279

Historical Rank

medical Degrees

Download Badge

Medical

William L. Dewey's Degrees

Bachelors Chemistry University of California, Berkeley

Why Is William L. Dewey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William L. Dewey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. (1970) (352)
Antineoplastic activity of cannabinoids. (1975) (310)
Cannabinoid pharmacology. (1986) (305)
μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization (2010) (247)
Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. (1981) (174)
Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. (1975) (166)
The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception (2018) (139)
CHARACTERISTICS OF TETRAHYDROCANNABINOL TOLERANCE * (1971) (134)
Narcotic-antagonist analgesics: interactions with cholinergic systems. (1969) (132)
Protein kinase inhibitor peptide (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function (2006) (131)
Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. (1980) (122)
How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? (2006) (102)
Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons (2009) (95)
Optically pure (+)-nicotine from (+/-)-nicotine and biological comparisons with (-)-nicotine. (1979) (94)
The effect of gut microbiome on tolerance to morphine mediated antinociception in mice (2017) (92)
Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet implanted mice. (1975) (83)
Morphine Tolerance in the Mouse Ileum and Colon (2008) (79)
The effect of narcotics and narcotic antagonists on the tail‐flick response in spinal mice (1969) (79)
Brain acetylcholine levels and inhibition of the tail-flick reflex in mice. (1969) (78)
The Effect of Protein Kinase C and G Protein-Coupled Receptor Kinase Inhibition on Tolerance Induced by μ-Opioid Agonists of Different Efficacy (2010) (76)
Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice (2007) (73)
Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys. (1982) (73)
Cannabis dependence and tolerance production. (1990) (73)
Involvement of phospholipid signal transduction pathways in morphine tolerance in mice (1999) (71)
The effect of 1-trans-delta 9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of rats. (1970) (70)
The spinal cord as a major site for the antinociceptive action of nicotine in the rat (1986) (70)
Fentanyl depression of respiration: comparison with heroin and morphine (2019) (69)
Effects of Glucose and Diabetes on Binding of Naloxone and Dihydromorphine to Opiate Receptors in Mouse Brain (1987) (66)
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists. (2009) (64)
A comparison of some pharmacological actions of morphine and Δ9-tetrahydrocannabinol in the mouse (1978) (63)
3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. (1976) (63)
Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction. (1981) (62)
9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine. (1977) (61)
Pharmacology of some Marijuana Constituents and Two Heterocyclic Analogues (1970) (61)
Neonatal pain: a comprehensive survey of attitudes and practices. (1993) (60)
Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. (1981) (58)
The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA (2003) (57)
β-Endorphin Response to Endurance Exercise: Relationship to Exercise Dependence (1993) (57)
Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. (1976) (57)
The Role of β-Arrestin2 in the Mechanism of Morphine Tolerance in the Mouse and Guinea Pig Gastrointestinal Tract (2012) (56)
ANTINOCICEPTIVE ACTIVITY OF THE NARCOTIC ANTAGONIST ANALGESICS AND ANTAGONISTIC ACTIVTY OF NARCOTIC ANALGESICS IN RODENTS (1971) (55)
Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors (2002) (55)
An in-vitro preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse. (2013) (55)
Interactions of thyrotropin releasing hormone and morphine sulfate in rodents. (1977) (53)
Site and mechanism of morphine tolerance in the gastrointestinal tract (2014) (49)
The effects of chronic administration of trans- 9 -tetrahydrocannabinol on behavior and the cardiovascular system of dogs. (1972) (47)
A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests (1994) (47)
Pharmacology Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice J. Pharmacol. exp. Ther., 193 (1975) 845–852 (1976) (47)
The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model (2016) (47)
Antipyretic, analgesic and anti-inflammatory effects of ?9-tetrahydrocannabinol in the rat (1973) (46)
Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents. (1972) (45)
Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice (2008) (45)
Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol. (1973) (44)
Region‐dependent attenuation of μ opioid receptor‐mediated G‐protein activation in mouse CNS as a function of morphine tolerance (2007) (44)
Morphine Decreases Enteric Neuron Excitability via Inhibition of Sodium Channels (2012) (43)
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. (2012) (42)
The effect of hypophysectomy on acupuncture analgesia in the mouse (1980) (41)
Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla (2012) (41)
Local production of O2- by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca2+ regulation. (2008) (41)
PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice. (2006) (40)
Antinociceptive action of the butyryl derivatives of cyclic guanosine 3':5'-monophosphate. (1978) (40)
Morphine dependence and diabetes. II. Alterations of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration. (1986) (39)
Pharmacological Characterization of Novel Water-Soluble Cannabinoids (2006) (39)
Oxycodone‐induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition (2018) (39)
CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward (2017) (39)
Effects of β-funaltrexamine (β-FNA) on morphine dependence in rats and monkeys (1986) (39)
Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. (2008) (37)
Involvement of Intracellular Calcium in Morphine Tolerance in Mice (1999) (37)
The correlation between antinociceptive activity of narcotics and their antagonists as measured in the mouse tail-flick test and increased synthesis of brain catecholamines. (1976) (36)
Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice. (1988) (36)
Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice. (1989) (35)
The role of neurotransmitters in stress-induced antinociception (SIA) (1982) (35)
3H-Δ9-tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: Penetration and regional distribution in rat brain (1980) (35)
PKC and PKA inhibitors reverse tolerance to morphine-induced hypothermia and supraspinal analgesia in mice. (2004) (35)
The gut-brain interaction in opioid tolerance. (2017) (34)
Connexin‐purinergic signaling in enteric glia mediates the prolonged effect of morphine on constipation (2017) (34)
Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and in siblings of victims of sudden infant death syndrome. (1987) (34)
Effects of HIV-1 Tat on Enteric Neuropathogenesis (2014) (34)
Differences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout mice. (2012) (34)
Morphine dependence and diabetes. I. The development of morphine dependence in streptozotocin-diabetic rats and spontaneously diabetic C57BL/KsJ mice. (1986) (33)
Naltrexone therapy of apnea in children with elevated cerebrospinal fluid β‐endorphin (1990) (33)
Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria (1977) (33)
A cannabinoid with cardiovascular activity but no overt behavioral effects (1977) (33)
Water-Soluble Derivatives of Δ1 Tetrahydrocannabinol (1972) (32)
Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception. (1980) (32)
Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception. (1986) (32)
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (2012) (31)
Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons. (1973) (31)
Morphine antinociception: evidence for the release of endogenous substance(s). (1979) (31)
Disposition of morphine in chronically infused rats: relationship to antinociception and tolerance. (1978) (30)
Serum cortisol and cerebrospinal fluid beta-endorphins in status epilepticus. Their possible relation to prognosis. (1993) (30)
Reversal of Morphine Analgesic Tolerance by Ethanol in the Mouse (2013) (30)
Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. (2005) (30)
Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists. (2011) (30)
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice (2010) (29)
Inhibition of rat brain mitochondrial calcium transport by chlordecone. (1979) (29)
Elevated CSF beta‐endorphin immunoreactivity in Rett's syndrome (1992) (28)
Discriminative stimulus and neurochemical mechanism of cathinone: a preliminary study. (1979) (28)
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity. (2013) (28)
Decrease in N-Methyl-d-aspartic Acid Receptor-NR2B Subunit Levels by Intrathecal Short-Hairpin RNA Blocks Group I Metabotropic Glutamate Receptor-Mediated Hyperalgesia (2007) (28)
Opioid-induced hypernociception is associated with hyperexcitability and altered tetrodotoxin-resistant Na+ channel function of dorsal root ganglia. (2012) (27)
Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes. (1976) (27)
Marihuana-like activity of new synthetic tetrahydrocannabinols (1975) (26)
3H-delta9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. (1977) (26)
Pharmacological potency of R- and S-3′-hydroxy-Δ9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity (1984) (26)
Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice. (2004) (26)
Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus (2011) (25)
Neurochemical correlates of chlordecone neurotoxicity. (1981) (25)
The effects of cannabinoids on body temperature and brain catecholamine synthesis. (1978) (25)
The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice. (1989) (25)
Interactions of narcotics with synaptosomal calcium transport. (1981) (24)
Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance (2007) (24)
Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators (2018) (24)
Cannabinoid effects on plasma corticosterone and uptake of 3H-corticosterone by mouse brain. (1978) (23)
The role of endogenous peptides in the action of opioid analgesics. (1986) (23)
Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link? (2019) (23)
Structure-Activity Relationship Studies of 6α- and 6β-Indolylacetamidonaltrexamine Derivatives as Bitopic Mu Opioid Receptor Modulators and Elaboration of the "Message-Address Concept" To Comprehend Their Functional Conversion. (2018) (22)
An investigation of the antinociceptive activity of calcitonin gene-related peptide alone and in combination with morphine: correlation to 45Ca++ uptake by synaptosomes. (1988) (22)
Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice (2016) (22)
Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrine (1987) (21)
Lysosomal cholesterol accumulation in macrophages leading to coronary atherosclerosis in CD38−/− mice (2016) (21)
A comparison of antinociception induced by foot shock and morphine. (1983) (21)
6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists. (2012) (20)
Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents. (2012) (20)
Sensitization of enteric neurons to morphine by HIV‐1 Tat protein (2015) (20)
Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone (2017) (20)
Differential effects of subcutaneous and intrathecal morphine administration on blood glucose in mice: comparison with intracerebroventricular administration. (1988) (20)
Ethanol Reversal of Cellular Tolerance to Morphine in Rat Locus Coeruleus Neurons (2013) (19)
Plasma ß‐endorphin immunoreactivity: Response to resistance exercise (1993) (19)
Synthesis and pharmacological evaluation of phenylethynyl[1,2,4]methyltriazines as analogues of 3-methyl-6-(phenylethynyl)pyridine. (2007) (19)
Comparison of the antinociceptive activity of intraventricularly administered acetylcholine to narcotic antinociception (1981) (19)
Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain. (1987) (19)
Problems of Drug Dependence, 2002: Proceedings of the 64th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. (2003) (18)
Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive mice. (1984) (18)
Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI) (2005) (18)
Cholinergic agents: antinociception without morphine type dependence in rats. (1985) (18)
A study of the effect of delta 9-tetrahydrocannabinol (delta 9-THC) on mammalian salivary flow. (1978) (18)
The effect of morphine, nalorphine, naloxone, pentazocine, cyclazocine and oxotremorine on the synthesis and release of acetylcholine by mouse cerebral cortex slices in vitro. (1970) (17)
mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo (2008) (17)
Calcitonin and Calcitonin Gene-Related Peptide (1989) (17)
Resistance exercise decreases beta-endorphin immunoreactivity. (1994) (17)
Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands. (2015) (16)
Possible hyperendorphinergic pathophysiology of the Rett syndrome. (1989) (16)
Some structural requirements for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids. (1976) (16)
Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice. (1982) (16)
Tolerance to morphine bradycardia in the rat. (1983) (16)
Δ9-THC and 11-OH-Δ9-THC: Behavioral effects and relationship to plasma and brain levels (1977) (16)
Effect of morphine exposure on mouse liver triglyceride formation. (1981) (15)
Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat. (1973) (15)
HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system (2016) (15)
Antagonism of antinociception in mice by glucose and fructose: comparison of subcutaneous and intrathecal morphine. (1988) (15)
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands. (2019) (15)
Glucose and Morphine-Induced Analgesia (1988) (15)
Effect of Tamoxifen and Brain-Penetrant Protein Kinase C and c-Jun N-Terminal Kinase Inhibitors on Tolerance to Opioid-Induced Respiratory Depression in Mice (2017) (15)
OPTICALLY PURE (+)-NICOTINE FROM (.+-.)-NICOTINE AND BIOLOGICAL COMPARISONS WITH (-)-NICOTINE (1979) (14)
Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment. (2019) (14)
Various factors which affect the rate of development of tolerance and physical dependence to abused drugs. (1984) (14)
Effects of divalent cations, lanthanum, cation chelators and an ionophore on acetylcholine antinociception. (1978) (14)
Stereospecificity of intraventricularly administered acetylmethylcholine antinociception. (1975) (14)
Stereoselective stimulus effects of 3-methylflunitrazepam and pentobarbital. (1984) (14)
Effect of propranolol on antinociceptive and withdrawal characteristics of morphine (1975) (14)
Stereoselective effect of morphine on antinociception and endogenous opioid peptide levels in plasma but not cerebrospinal fluid of dogs. (1991) (14)
Beta-endorphin in cerebrospinal fluid and serum after severe head injury. (1990) (14)
A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse. (1992) (13)
Studies on the mechanism of hypoglycemia induced by intrathecal morphine: dissociation from behavioral effects, effects of tolerance and depletion of liver glycogen. (1989) (13)
Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors (2019) (13)
Annual report: dependence studies of new compounds in the rhesus monkey (1980). (1981) (13)
Hypoglycemia induced by intrathecal opioids in mice: stereospecificity, drug specificity and effect of fasting. (1990) (13)
A comparative study of the disposition of (-)-delta 9-tetrahydrocannabinol in neuroblastoma and glioma cells in tissue culture: relation cellular impairment. (1977) (12)
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. (2016) (12)
Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol. (1985) (12)
Local production of O 2 U − by NAD ( P ) H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes : cADPR-mediated Ca 2 + regulation (2008) (12)
Some pharmacological effects of phenitrone and its interaction with 9 -THC. (1972) (11)
Acetylcholine Induced Antinociception: Comparisons to Opiate Analgesia (1981) (11)
An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway. (1991) (11)
6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand. (2016) (11)
Plasma beta-endorphin immunoreactivity: response to resistance exercise. (1993) (11)
The mouse paw withdrawal assay: a method for determining the effect of calcitonin gene-related peptide on cutaneous heat nociceptive latency time. (1993) (11)
The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species. (1982) (10)
Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits. (1985) (10)
Preparation and activity of -substituted acetylcholine iodides. (1971) (10)
Evidence for the importance of N-dealkylation in opioid pharmacology☆ (1978) (10)
THE DISCRIMINATIVE STIMULUS PROPERTIES OF DELTA-9-TETRAHYDROCANNABINOL: GENERALIZATION TO SOME METABOLITES AND CONGENERS1 (1984) (10)
3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol. (1982) (10)
Further studies on the antinociceptive effects ofΔ acid (1990) (10)
Specific Localization of β-Arrestin2 in Myenteric Plexus of Mouse Gastrointestinal Tract (2014) (9)
PHARMACOLOGICAL ACTIVITY OF DELTA-9-THC METABOLITES AND ANALOGS OF CBD, DELTA-8-THC AND DELTA-9-THC* (1984) (9)
Some 9-hydroxycannabinoid-like compounds. Synthesis and evaluation of analgesic and behavioral properties. (1979) (9)
Effects of Δ9-THC on the synaptosomal uptake of 3H-tryptophan and 3H-choline (1978) (9)
Increased plasma beta-endorphin immunoreactivity in scuba divers after submersion. (1987) (9)
Evidence for the existence of peptide and nonpeptide morphine-like materials in mouse brain: effect of an analgesic intracerebroventricular dose of acetylcholine on their levels J. Pharmacol. Exp. Ther., 222 (1982) 612–616 (1982) (9)
The role of endogenous opioids as mediators of the hypothermic effects of intrathecally administered calcium and calcitonin gene-related peptide in mice. (1993) (9)
The effect of sodium ion on antinociception and opiate binding in vivo. (1978) (9)
Characterization of the interaction of pentazocine and tripelennamine: Drug discrimination and mu-receptor binding assay (1984) (9)
Corrections to Design, Synthesis, and Biological Evaluation of 6α- and 6β- N -Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists (2009) (9)
A characterization of the antinociception produced by intracerebroventricular injection of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate in mice. (1986) (9)
Antinociceptive and lethal effects of intraventricularly administered barium and strontium: antagonism by atropine sulfate or naloxone hydrochlorine. (1983) (8)
Role of CD38, a Cyclic ADP-Ribosylcyclase, in Morphine Antinociception and Tolerance (2010) (8)
Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators. (2019) (8)
Effect of Sleep Loss on β-Endorphin Activity, Epinephrine Levels, and Ventilatory Responsiveness (1987) (8)
Annual report: dependence studies on new compounds in the rhesus monkey (1979). (1979) (8)
Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice. (1992) (8)
Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice (2020) (8)
Electrophysiological Characteristics of Enteric Neurons Isolated from the Immortomouse (2013) (8)
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. (1990) (8)
Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord. (1997) (8)
A Comparison of the Subcellular Distribution of Cannabinoids in the Brains of Tolerant and Nontolerant Dogs, Rats, and Mice After Injecting Radiolabeled Δ9-Tetrahydrocannabinol (1976) (8)
The effect of delta9-tetrahydrocannabinol on the conversion of [3H]trypotphan to 5-[3H] hydroxytryptamine in the mouse brain. (1978) (8)
Simvastatin promotes NPC1‐mediated free cholesterol efflux from lysosomes through CYP7A1/LXRα signalling pathway in oxLDL‐loaded macrophages (2016) (7)
Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons (2018) (7)
Some behavioral and toxicological effects of amyl nitrite. (1973) (7)
The activity of several peptide fragments of parathyroid hormone, alone and in combination with salmon calcitonin and morphine, in antinociceptive tests in the mouse. (1990) (7)
Derivatives of apomorphine and of other N-substituted norapomorphines. (1976) (7)
Excretion of trans- 9 -tetrahydrocannabinol and its metabolites in intact and bile duct-cannulated rats. (1973) (7)
Possible effects of normetabolites on the subjective and reinforcing characteristics of opioids in animals and man. (1978) (7)
Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia. (1994) (7)
Antagonism of the morphine-induced locomotor activation of mice by fructose: comparison with other opiates and sugars, and sugar effects on brain morphine. (1991) (7)
Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine. (1987) (7)
The effects of narcotic analgesics and narcotic antagonists on ganglionic transmission in the rat. (1976) (6)
INTERACTIONS OF ACTIVE CONSTITUENTS OF MARIHUANA WITH OTHER DRUGS IN THE NEURON * (1976) (6)
Contribution of acid sphingomyelinase in the periaqueductal gray region to morphine-induced analgesia in mice (2012) (6)
Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys. (1986) (6)
Adrenalectomy reverses the effects of delta-9-THC on mouse brain 5-hydroxytryptamine turnover. (1981) (6)
Morphine dependence in single enteric neurons from the mouse colon requires deletion of β‐arrestin2 (2014) (6)
Structure-activity relationships of enkephalins in the stimulated guinea pig ileum. (1976) (6)
A new technique for the in vivo bioassay of opiates and other drugs on mouse spinal cord. (1981) (6)
Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia. (2021) (6)
The complete writing guide to NIH behavioral science grants (2007) (6)
Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators. (2018) (6)
APPARENT IN VIVO ACETYLCHOLINE TURNOVER RATE IN WHOLE MOUSE BRAIN: EVIDENCE FOR A TWO COMPARTMENT MODEL BY TWO INDEPENDENT KINETIC ANALYSES (1979) (6)
Effect of tamoxifen and brain penetrant PKC and JNK inhibitors on tolerance to opioid-induced respiratory depression in mice (2017) (6)
The effects of cannabinoids on rat brain synaptosomes. (1978) (6)
The effects of narcotic-antagonist analgesics on rat brain cholinesterases. (1969) (5)
Contemporary Drug Abuse (2003) (5)
Protein Kinase A activity is increased in mouse lumbar spinal cord but not brain following morphine antinociceptive tolerance for 15 days. (2005) (5)
Synthesis and pharmacological activity of some 9-substituted .DELTA.8-tetrahydrocannabinol (THC) analogs (1984) (5)
Endogenous dynorphin modulates calcium-mediated antinociception in mice (1993) (5)
Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. (1979) (5)
Background on animal testing in the drug delivery systems program. (1981) (5)
Reversal of oxycodone and hydrocodone tolerance by diazepam (2017) (5)
The discriminative stimulus properties of the R2 isomer of viminol (1984) (5)
In vitro alteration of the subcellular distribution of 3H-reserpine in the rat forebrain by delta 9-tetrahydrocannabinol. (1976) (4)
A comparison of some stereochemical requirements of the acetylcholinesterase and muscarinic receptor areas. (1970) (4)
The "culture" of pain control: A review of opioid-induced dysbiosis (OID) in antinociceptive tolerance. (2019) (4)
A comparative study of the effect of methionine enkephalin upon the stereospecific binding of an opiate agonist and an antagonist in mice and rats. (1977) (4)
Changes in the levels of several endogenous opioid peptides in dog cerebrospinal fluid following morphine administration. (1993) (4)
Effect of intrathecal morphine on the fate of glucose. Comparison with effects of insulin and xanthan gum in mice. (1993) (4)
Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice (2022) (4)
(-)-8beta-hydroxymethyl-delta1-tetrahydrocannabinol: a novel physiologically active analog of delta1-tetrahydrocannabinol. (1976) (4)
Effect of antinociceptive doses of oxotremorine on mouse brain acetylcholine turnover rate. (1980) (4)
The Role of 5-HT2a/2c Receptors in Nociception and Opioid Antinociception: a Review of the Preclinical Literature (2017) (4)
Short- and long-term factors in tolerance to morphine-induced antinociception: Single or multiple mechanisms? (1991) (4)
Enhanced Sensitivity of α3β4 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation (2016) (4)
Potencies of diazepam metabolites in rats trained to discriminate diazepam. (1986) (4)
The central and peripheral effects of delta-9-tetrahydrocannabinol on gastrointestinal transit in mice. (1986) (3)
Δ9 THC induced elevations of mouse brain tryptophan and consequent increased serotonin production (1976) (3)
Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents. (1984) (3)
Analysis of carbenoxolone by ultra-high-performance liquid chromatography tandem mass spectrometry in mouse brain and blood after systemic administration. (2018) (3)
A survey of the teaching of pain control at the predoctoral level. (1976) (3)
Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin. (1978) (3)
Pharmacologic and toxicologic evaluation of 2-(N-tetradecyl-N-ethylamino)-2-methyl-1,3-propanediol hydrochloride, an inhibitor of intestinal absorption. (1968) (3)
The Guts of the Opioid Crisis. (2021) (2)
Antagonism of barium chloride lethality by atropine and naloxone analysis by a multivariate logistic model. (1979) (2)
Effects of pyrazolopyridines and a triazolopyridazine on the pentobarbital discriminative stimulus (2004) (2)
Pharmachology The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species Life Sci., 31 (1982) 1741–1743 (1983) (2)
Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists. (2022) (2)
β-Funaltrexamine (β-FNA) and morphine dependence (1984) (2)
Rapid tolerance to morphine in the myenteric neurons of the small intestine is independent of β-arrestin-2 and mediated by PKC (2020) (2)
THE PHARMACOLOGY OF PENTAZOCINE (1973) (2)
Intrathecal morphine and insulin cause hypoglycemia in mice by different mechanisms. (1990) (2)
Effects of the intracerebroventricular injection of antinociceptive doses of acetylcholine on the stereospecific binding of 3H-dihydromorphine. (1981) (2)
Prolonged ethanol administration prevents the development of tolerance to morphine-induced respiratory depression. (2019) (2)
Correlation between the effects of several cannabinoids on catecholamine synthesis, body temperature, and behavior (1976) (2)
Narcotic-antagonist assay procedures in dogs. (1973) (2)
THEMED ISSUE: GPCR RESEARCH PAPER Involvement of PKCa and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of m-opioid receptors in mature brain neurons (2009) (2)
Comparison of [(3)H]Glyburide binding with opiate analgesia, tolerance, and dependence in ICR and Swiss-Webster mice. (2000) (2)
Effects of branched-chain amino acids on β-endorphin in the pituitary of the rat (1985) (2)
Chapter 4. Analgetics–Strong and Weak (1967) (2)
Effects of hyperbaric simulation of scuba diving pressure on plasma β-endorphin (1991) (2)
Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation. (2017) (2)
Sodium-induced alterations of opiate effects on the binding of 3H-dihydromorphine to mouse brain homogenates. (1978) (2)
The need for an adverse drug reaction prediction and prevention program. (1973) (2)
Chronic Delta9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering protein kinase A activity in mouse brain and spinal cord. (2005) (1)
The role of beta-endorphin in respiratory disorders in man. (1988) (1)
Role of CD38 in Morphine Tolerance (2007) (1)
Effects of HIV‐1 tat protein on excitability of enteric neurons (2013) (1)
Structure activity relationships of the cannabinoids in blocking synaptosomal serotonin uptake (1975) (1)
Mo1578 - The Effect of a G-Protein Biased Ligand, TRV130, on Opioid-Induced Constipation (2018) (1)
SOME 11-SUBSTITUTED TETRAHYDROCANNABINOLS. SYNTHESIS AND COMPARISON WITH THE POTENT CANNABINOID METABOLITES 11-HYDROXYTETRAHYDROCANNABINOLS (1979) (1)
Comparison of the effects of salmon calcitonin (sCT) and calcitonin gene-related peptide (CGRP) in a number of in vivo and in vitro tests (1986) (1)
Synthesis of two enzyme resistant enkephalin analogs possessing enhanced analgesic activity. (1978) (1)
Effects of diving experience on submersion-induced increases in plasma levels of β-endorphin in scuba divers (1991) (1)
The Role of Toll‐Like Receptor 4 in Enteric Glia (2015) (1)
Chronic Δ9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering Protein Kinase A activity in mouse brain and spinal cord (2005) (1)
Generating Hypertrophic Adipocytes from 3T3 L1 Cell Line and Characterizing the Phenotypic Transition (2016) (1)
Effect of soman on the cholinergic system in mouse brain (1986) (1)
Comparison of the antinociceptive activity of intraventricularly administered acetylcholine to narcotic antinociception N.W. Pedigo and W.L. Dewey, Neurosci. Lett., 26 (1981) 85–90 (1982) (1)
Bad manners, not good (1995) (1)
DIFFERENCES BETWEEN THE MECHANISM OF ACTION OF MORPHINE ANTINOCICEPTION IN MICE AND RATS (1980) (1)
Failure of branched-chain amino acids to affect synaptosomal uptake of norepinephrine and dopamine. (1985) (1)
Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts. (1987) (1)
Correction: Morphine Decreases Enteric Neuron Excitability via Inhibition of Sodium Channels (2013) (1)
Modulation of synaptosomal free intracellular calcium in naive and morphine-tolerant mice: correlation of calcium modulation in vitro and in vivo to tolerance development. (1989) (1)
delta 9-THC and 11-OH-delta 9-THC: behavioral effects and relationship to plasma and brain levels. (1977) (1)
Resistance exercise decreases-endorphin immunoreactivity (2005) (1)
9-NOR-9-HYDROXYHEXAHYDROCANNABINOLS. SYNTHESIS, SOME BEHAVIORAL AND ANALGESIC PROPERTIES, AND COMPARISON WITH THE TETRAHYDROCANNABINOLS (1976) (1)
Evidence for the release of endogenous opiates by morphine. (1982) (1)
The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan). (1967) (1)
Morphine tolerance is dependent upon PKC activation at the level of the mu-opioid receptor (2005) (0)
Enteric neurons of the adult mouse; successful isolation through immunoselection and immunocytochemical and electrophysiological characterization (2011) (0)
210 EFFECTS OF TRAINING SPECIFICITY ON THE B-ENDORPHIN RESPONSE TO EXERCISE (1994) (0)
G‐protein coupled receptor kinase 2(GRK2) is involved in μ‐receptor signaling in the mouse ileum but not colon (2008) (0)
Differential effects of calcitonin gene-related peptide in tests utilizing thermal versus nociceptive stimuli. (1990) (0)
β‐arrestin2 expression is localized in cholinergic but not nitrergic motor neurons in the mouse longitudinal musclemyenteric plexus (LMMP) (2013) (0)
Electrophysiological characterization of postnatal enteric neuron cell line (2010) (0)
Biomedical Research: Critical Issues for the 1990s (1990) (0)
CD38: Novel interaction with morphine analgesic pathways in mice (2006) (0)
A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys. (1977) (0)
Microsoft Word-Jacob Revised MS110775 01242018_Hamid edit.docx (2018) (0)
Ethanol and pregabalin reverse oxycodone tolerance (2018) (0)
The effects of phenitrone, a reported hashish antagonist, on the overt behavior of cats. (1974) (0)
1198 – SUBCELLULAR DISTRIBUTION OF 3H-Δ9-TETRAHYDROCANNABINOL IN BRAINS OF NONTOLERANT AND TOLERANT RATS (1977) (0)
1039 – INTRAPERITONEAL INFUSION OF NARCOTIC ANTAGONISTS IN RAT (1977) (0)
INTRODUCTION OF THE NATHAN B. EDDY MEMORIAL AWARD RECIPIENT (1997) (0)
HIGH DIETARY SALT AND FRUCTOSE INCREASE NFAT 5 EXPRESSION IN THE KIDNEY AND LIVER OF SPRAGUE DAWLEY RATS (2017) (0)
Enhanced expression and activity of NAD(P)H oxidase in mouse periaqueductal gray neurons during morphine antinociceptive tolerance (2006) (0)
Antineoplastic Aetivity of Cannabinoids (1999) (0)
signalling with ability to activate internalization (2010) (0)
CD38 prevents morphine‐tolerance development in mouse distal colon (2009) (0)
Investigation of the opiate dependence liability of dynorphin fragments and α-neo-endorphin in morphine-dependent rhesus monkeys (1983) (0)
Cutaneous Afferent Neurons Currents in + and K + Ganglion on Voltage-Gated Na Effects of a Chronic Compression of the Dorsal Root (2015) (0)
Amelioration of the foam cell formation by simvastatin due to increased expression of Niemann‐Pick disease type C1 protein and enhanced lysosomal lipids transport (606.4) (2014) (0)
General Anesthesia : Intravenous and Inhalational Agents 291 (2003) (0)
Su1940 The Role of the Gastrointestinal Microbiota in Opioid-Induced Analgesic Tolerance (2016) (0)
SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF SOME 9‐SUBSTITUTED Δ8‐TETRAHYDROCANNABINOL (THC) ANALOGS (1984) (0)
An In Vitro and In Vivo study of BNAP: A Novel Peripherally Selective μ‐opioid Receptor Antagonist (2015) (0)
Narcotic Analgesics And Antagonist (2019) (0)
μ-Opioid Receptors Co-Expressed in Cholinergic Neurons of Mouse Ileum Myenteric Plexus Develop Tolerance to Chronic Morphine Exposure (2017) (0)
The role of β‐arrestin 2 and GRK5/6 in development of differential tolerance to morphine in the colon and ileum (653.3) (2014) (0)
Role of endogenous peptides in the action of narcotics (1986) (0)
Billy R Martin (2009) (0)
Rational Design, Chemical Syntheses, and Biological Evaluations of Peripherally Selective Mu Opioid Receptor Ligands as Potential Opioid Induced Constipation Treatment. (2022) (0)
The identification of {micro} opioid receptors on colonic circular smooth muscle cells (2008) (0)
The Effect of Colonic Inflammation on Morphine Induced Antinociceptive Tolerance (2018) (0)
Differential development of tolerance to μ‐opioid receptor agonists in the mouse colon (2012) (0)
Mechanism of the synergistic lethality between pentazocine and vasopressin in the rat. (1973) (0)
Opiate-induced alterations of calcium exchange in mouse neuroblastoma (nb2a) cells. Abstr. (1977) (0)
The effect of morphine on a K+ channel from a murine enteric neuron cell line derived from the H‐2kb‐tsA58 mouse (2009) (0)
Morphine‐induced tolerance and dependence develops in the mouse isolated ileum but not colon (2008) (0)
Antimuscarinic Activity of a Novel Indan Analogue of Aprophen and Caramiphen. (1992) (0)
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG Toxicity. (2022) (0)
Morphine analgesia in spinal mice and rats: cholinergic mechanisms (1976) (0)
Role of Acetaldehyde in Ethanol Reversal of Morphine Tolerance (2018) (0)
Inhibition of Adipocyte and Preadipocyte Fusion Reduces Abdominal Adipose Tissue Mass in Obese Mice (2016) (0)
The identification of μ opioid receptors on colonic circular smooth muscle cells (2008) (0)
Assessing Opioid Tolerance Mechanisms in an Isolated Murine Dorsal Root Ganglia Neuron Model (2018) (0)
3′-HYDROXY- AND (.+-.)-3′,11-DIHYDROXY-Δ9-TETRAHYDROCANNABINOL: (THC) BIOLOGICALLY ACTIVE METABOLITES OF Δ9-TETRAHYDROCANNABINOL (1983) (0)
Effect of HIV‐1 Tat on enteric neuropathogenesis (653.6) (2014) (0)
Marihuana and opiate interactions with hormonal induced systems in cell culture. (1979) (0)
δ Opioid receptor agonist, DPDPE, enhances neuronal excitability in mouse enteric nervous system (653.4) (2014) (0)
Some effects of the behaviorally active drug, phenitrone, a purported hashish and LSD antagonist, on brain noradrenergic and serotonergic systems. (1975) (0)
Morphine decreases neuronal excitability in mouse enteric neurons via alterations in Na+ channel kinetics (2012) (0)
Novel pharmacology of the inhibitory effects of JWH015 in the mouse gastrointestinal tract (2011) (0)
Effects of hyperbaric simulation of scuba diving pressure on plasma beta-endorphin. (1991) (0)
Neural Substrates of Opioid Tolerance and Dependence (1986) (0)
Running Title : Ethanol Reversal of Oxycodone and Hydrocodone Tolerances (2017) (0)
DERIVATIVES OF APOMORPHINE AND OF OTHER N-SUBSTITUTED NORAPOMORPHINES (1977) (0)
ENDORPHIN RESPONSE TO EXERCISE AND RECOVERY IN TRAINED DISTANCE RUNNERS 1141 (1997) (0)
Stereospecific effects of morphine on plasma opioid peptide levels and nociception in dogs (1986) (0)
Chronic morphine induces hyperexcitability and biophysical remodeling of tetrodotoxin‐resistant Na+‐ and TRPV1 –channels in mouse dorsal root ganglia (2011) (0)
Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia (2020) (0)
Chronic Morphine Induces IL-18 in Ileum Myenteric Plexus Neurons Through Mu-opioid Receptor Activation in Cholinergic and VIPergic Neurons (2022) (0)
Colonic Supernatants from Chronic Morphine Exposed Mice Induce Morphine Tolerance in Naïve Dorsal Root Ganglion Neurons that is Mitigated by Oral Vancomycin Delivery (2017) (0)
1155 – A CORRELATION BETWEEN THE ANTINOCICEPTIVE AND INHIBITION OF OPIATE RECEPTOR BINDING ACTIVITIES OF A NUMBER OF CHOLINERGIC AGENTS (1978) (0)
The effect of ethanol on loperamide‐induced tolerance (653.15) (2014) (0)
1149 – ANALGESIC AND PHYSICAL DEPENDENCE LIABILITY OF TWO NEW ESTERS OF N-METHYLPIPERIDINE (1978) (0)
PKC and PKA inhibitors reverse acute tolerance to low‐ and moderate‐ but not high‐efficacy mu‐opioid agonists (2008) (0)
Chronic morphine enhances nicotine responses in single mouse enteric neurons (659.9) (2014) (0)
Morphine induced tolerance to mouse intestinal but not colonic transit and constipation (2008) (0)
SOME 9-HYDROXYCANNABINOID-LIKE COMPOUNDS. SYNTHESIS AND EVALUATION OF ANALGESIC AND BEHAVIORAL PROPERTIES (1979) (0)
Behavioral procedures: an overview. (1973) (0)
Dynamic In vivo Imaging of NADPH Oxidase Gene Expression to Monitor its Involvement in Morphine's Actions (2008) (0)
Characterization of a Potential KOR/DOR Dual Agonist with No Apparent Abuse Liability via a Complementary Structure-Activity Relationship Study on Nalfurafine Analogues. (2022) (0)
Characterization of the Ability of Diazepam to Reverse Prescription Opioid Tolerance (2017) (0)
WASSERLOESLICHE DERIVATE VON DELTA(1)-TETRAHYDROCANNABINOL (1972) (0)
Cannabinoid induced elevations in plasma endogenous corticosterone levels correlate with increased whole brain uptake of 3H-corticosterone in adrenalectomized mice (1977) (0)
RACK1 inhibitors reveal PKC gamma and epsilon in mediating morphine tolerance (2006) (0)
Effects of delta9-THC on the synaptosomal uptake of 3H-tryptophan and 3H-choline. (1978) (0)
Alterations in β‐arrestin expression in guinea‐pig ileum and colon following morphine tolerance (2010) (0)
Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues. (1984) (0)
Reversal of the Development of Antinociceptive Effects to Chronic Morphine in Mice by Fecal Microbiota Transplantation (FMT) (2019) (0)
Location, Location, Location: The Effect of Lorcaserin via Different Routes of Administration on Acute Oxycodone Analgesia (2017) (0)
HASHISH: SYNTHESIS AND CENTRAL NERVOUS SYSTEM ACTIVITY OF SOME NOVEL ANALOGS OF CANNABIDIOL AND OXEPIN DERIVATIVES OF Δ9-TETRAHYDROCANNABINOL (1985) (0)
Electrophysiological characteristics of enteric neurons from immortomouse (2011) (0)
Effects of endogenous calcium regulating peptides on opiate actions. (1992) (0)
Effects of branched-chain amino acids on beta-endorphin in the pituitary of the rat. (1985) (0)
Opioid-like adverse effects of tianeptine in male rats and mice (2022) (0)
Role of Acetaldehyde in Ethanol Reversal of Tolerance to Morphine-Induced Respiratory Depression in Mice (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William L. Dewey?

William L. Dewey is affiliated with the following schools:

Virginia Commonwealth University